Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;52(12):922-4.
doi: 10.1136/jcp.52.12.922.

Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up

Affiliations

Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up

G Cserni. J Clin Pathol. 1999 Dec.

Abstract

Aim: To assess the value of the intensive histological work up of axillary sentinel lymph nodes (SLN) to demonstrate regional metastatic disease.

Methods: From a series of 58 successful lymphatic mapping procedures, 78 SLN were analysed by serial sections (mean of 49 levels/SLN) and by immunostaining to cytokeratin and epithelial membrane antigen, and the results compared with those obtained by assessing the central cross section.

Results: The central cross section would have failed to detect metastases in eight of 26 lymph nodes (31%) in patients with breast cancer metastasising to the SLN only. This would have led to a false negative node status in six of 21 patients (29%). Two micrometastases were detected with the aid of immunostains.

Conclusions: The results suggest the need to examine SLN at multiple levels and to use immunohistochemistry in negative cases. Serial sections are also useful in the case of micrometastases, as some of these may convert to macrometastases at deeper levels. Multiple level investigation of SLN and immunohistochemistry in the event of the negativity of standard stains would result in improved staging and an increase in the proportion of node positive disease detected.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. J Clin Oncol. 1997 Jun;15(6):2345-50 - PubMed
    1. Am Surg. 1998 Jan;64(1):28-31; discussion 32 - PubMed
    1. Ann Surg Oncol. 1998 Jun;5(4):310-4 - PubMed
    1. Int J Cancer. 1998 Dec 18;79(6):645-51 - PubMed
    1. Arch Pathol Lab Med. 1998 Aug;122(8):687-90 - PubMed

Publication types